HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.

Abstract
IL-3 is an important cytokine that regulates hematopoiesis and functions as a link between the immune and the hematopoietic system. In this study, we investigated the role and mechanism of IL-3 action on human osteoclast formation and bone resorption using PBMCs. PBMCs differentiate into functional osteoclasts in the presence of M-CSF and receptor activator of NF-kappaB ligand as evaluated by 23c6 expression and bone resorption. We found that IL-3 dose-dependently inhibited formation of 23c6-positive osteoclasts, bone resorption and C-terminal telopeptide of type I collagen, a collagen degradation product. The inhibitory effect of IL-3 on bone resorption was irreversible. To investigate the mechanism of IL-3 action, we analyzed the effect of IL-3 on the receptor activator of NF-kappaB and c-Fms receptors and c-Fos, PU.1, NFAT cytoplasmic 1, and RelB transcription factors essential for osteoclastogenesis. IL-3 significantly inhibited c-Fms and downregulated both PU.1 and c-Fos at both mRNA and protein level. Furthermore, IL-3-treated cells showed increased expression of dendritic cell markers CD1a and CD80 and decreased expression of monocyte/macrophage marker CD14. Interestingly, IL-3 inhibited formation of human osteoclasts derived from blood monocytes and bone marrow cells of osteoporotic individuals. Thus, IL-3 may have therapeutic potential as an antiosteolytic agent in treatment of osteoporosis.
AuthorsNavita Gupta, Amruta P Barhanpurkar, Geetanjali B Tomar, Rupesh K Srivastava, Supinder Kour, Satish T Pote, Gyan C Mishra, Mohan R Wani
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 185 Issue 4 Pg. 2261-72 (Aug 15 2010) ISSN: 1550-6606 [Electronic] United States
PMID20644169 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-3
  • Osteoprotegerin
  • RANK Ligand
  • Receptors, Interleukin-3
  • Receptor, Macrophage Colony-Stimulating Factor
Topics
  • Adult
  • Aged
  • Bone Resorption (prevention & control)
  • Cell Differentiation (drug effects)
  • Cell Lineage (drug effects)
  • Cells, Cultured
  • Dendritic Cells (cytology, drug effects, metabolism)
  • Dose-Response Relationship, Drug
  • Down-Regulation (drug effects)
  • Flow Cytometry
  • Gene Expression (drug effects)
  • Humans
  • Interleukin-3 (pharmacology)
  • Middle Aged
  • Osteoclasts (cytology, drug effects, metabolism)
  • Osteoprotegerin (genetics, metabolism)
  • RANK Ligand (pharmacology)
  • Receptor, Macrophage Colony-Stimulating Factor (genetics, metabolism)
  • Receptors, Interleukin-3 (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: